Covid vaccine protection ‘short lived,’ booster doses essential, study confirms
‘Continual updating of our vaccinations and booster shots is critical,’ scientists say
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Protection offered by Covid-19 vaccines against infection with the novel coronavirus is “short-lived,” according to a new study that says up-to-date booster doses are essential for “dependable” immune defense against the virus.
The findings, published last week in the journal PNAS, provide additional evidence that booster vaccination is a crucial approach towards the curtailment of breakthrough infections, in which a person becomes infected despite being vaccinated, as well as from reinfection with the Covid-19 virus.
In the study, researchers, led by those at the Yale School of Public Health in the US, quantified the likelihood of future infection following natural infection or vaccination by the Moderna, Pfizer, Johnson & Johnson, or Oxford-AstraZeneca vaccines.
They say the risk of breakthrough infections depends on the vaccine type, with mRNA vaccines like those by Pfizer and Moderna offering the greatest duration of protection.
The research found that mRNA vaccines offer immune protection nearly three times as long as that from natural infection and the Johnson & Johnson and Oxford-AstraZeneca vaccines.
“The mRNA vaccines produce the highest levels of antibody response and in our analysis confer more durable protection than other vaccines or exposures,” study lead author Jeffrey Townsend from the Yale School of Public Health said.
“However, it is important to remember that natural immunity and vaccination are not mutually exclusive. Many people will have partial immunity from multiple sources, so understanding the relative durability is key to deciding when to provide a boost to your immune system,” Dr Townsend said.
The study finds that “dependable protection” against reinfection with the novel coronavirus requires up-to-date boosting with vaccines that are adapted to address changes in the virus that occur as part of its natural evolution over time.
“We tend to forget that we are in an arms race with this virus, and that it will evolve ways to evade both our natural and any vaccine-derived immune response,” Alex Dornburg, another co-author of the study, said.
“As we have seen with the Omicron variant, vaccines against early virus strains become less effective at combating new strains of the virus,” Dr Dornburg said.
In the study, scientists estimated infection risks with the Covid-19 virus by comparing it with the reinfection probabilities seen in endemic coronaviruses such as those that cause common colds.
“SARS-CoV-2 mirrors other endemic coronaviruses that also evolve and reinfect us despite natural immunity to earlier strains,” Dr Townsend said.
Citing some of the limitations of the study, researchers says the focus on antibody-mediated immunity in the research “mask” other factors like variation in age, immune status, infection severity, vaccine response, and the immune system’s T- and B-cell memory.
“Our approach does not account for these factors or their interactions,” scientists said, adding however that antibodies have been shown to be the dominant component of the immune system providing protection against infection by the novel coronavirus.
“Continual updating of our vaccinations and booster shots is critical to our fight against SARS-CoV-2,” Dr Townsend added.
Subscribe to Independent Premium to bookmark this article
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments